BR1100601A - Preparação de uma suspensão aquosa para injeção para combater dor; processo para produzir a mesma; e uso desta para alìvio da dor - Google Patents

Preparação de uma suspensão aquosa para injeção para combater dor; processo para produzir a mesma; e uso desta para alìvio da dor

Info

Publication number
BR1100601A
BR1100601A BR1100601-3A BR1100601A BR1100601A BR 1100601 A BR1100601 A BR 1100601A BR 1100601 A BR1100601 A BR 1100601A BR 1100601 A BR1100601 A BR 1100601A
Authority
BR
Brazil
Prior art keywords
preparation
less
pain
injection
aqueous suspension
Prior art date
Application number
BR1100601-3A
Other languages
English (en)
Inventor
Eric W Ackerman
Am Nuenen
Rene J E Grouls
Hendrikus H M Korsten
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to BR1100601-3A priority Critical patent/BR1100601A/pt
Publication of BR1100601A publication Critical patent/BR1100601A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A61K31/24—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group having an amino or nitro group
    • A61K31/245—Amino benzoic acid types, e.g. procaine, novocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A61P23/02—Local anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Anesthesiology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Emergency Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Dermatology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
BR1100601-3A 1990-03-20 1997-05-13 Preparação de uma suspensão aquosa para injeção para combater dor; processo para produzir a mesma; e uso desta para alìvio da dor BR1100601A (pt)

Priority Applications (1)

Application Number Priority Date Filing Date Title
BR1100601-3A BR1100601A (pt) 1990-03-20 1997-05-13 Preparação de uma suspensão aquosa para injeção para combater dor; processo para produzir a mesma; e uso desta para alìvio da dor

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NL9000634A NL9000634A (nl) 1990-03-20 1990-03-20 Suspensie-injectiepreparaat op waterbasis, werkwijze voor de bereiding daarvan en toepassing van dit preparaat voor pijnbestrijding.
BR1100601-3A BR1100601A (pt) 1990-03-20 1997-05-13 Preparação de uma suspensão aquosa para injeção para combater dor; processo para produzir a mesma; e uso desta para alìvio da dor

Publications (1)

Publication Number Publication Date
BR1100601A true BR1100601A (pt) 2000-04-18

Family

ID=19856770

Family Applications (1)

Application Number Title Priority Date Filing Date
BR1100601-3A BR1100601A (pt) 1990-03-20 1997-05-13 Preparação de uma suspensão aquosa para injeção para combater dor; processo para produzir a mesma; e uso desta para alìvio da dor

Country Status (15)

Country Link
US (1) US5346903A (pt)
EP (1) EP0521070B1 (pt)
JP (1) JPH05507466A (pt)
AT (1) ATE121631T1 (pt)
AU (1) AU646857B2 (pt)
BR (1) BR1100601A (pt)
CA (1) CA2077641C (pt)
DE (1) DE69109279T2 (pt)
DK (1) DK0521070T3 (pt)
ES (1) ES2074269T3 (pt)
FI (1) FI98890C (pt)
GR (1) GR3015940T3 (pt)
NL (1) NL9000634A (pt)
NO (1) NO300114B1 (pt)
WO (1) WO1991014455A1 (pt)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5206267A (en) * 1991-05-09 1993-04-27 Morton Shulman Pain controlling composition and method of preparation
US5635540A (en) * 1994-12-09 1997-06-03 The University Of Virginia Patent Foundation Stabilized topical pharmaceutical preparations
US6077545A (en) 1995-10-30 2000-06-20 Matrix Pharmaceuticals, Inc. Process and composition for therapeutic cisplatin (CDDP)
EA001257B1 (ru) * 1996-03-26 2000-12-25 Эли Лилли Энд Компани Бензотиофены, содержащие их фармацевтические композиции и способы лечения патологических состояний с их использованием
US6835194B2 (en) * 1999-03-18 2004-12-28 Durect Corporation Implantable devices and methods for treatment of pain by delivery of fentanyl and fentanyl congeners
US6541021B1 (en) * 1999-03-18 2003-04-01 Durect Corporation Devices and methods for pain management
US7074803B2 (en) * 2001-03-02 2006-07-11 Durect Corporation Opioid formulations
EP1389121B1 (en) 2001-04-24 2012-02-22 Purdue Research Foundation Method and compositions for treating mammalian nerve tissue injuries
US20030181426A1 (en) * 2002-02-11 2003-09-25 Eisenach James C. Compositions and methods for treating pain using cyclooxygenase-1 inhibitors
US7838034B2 (en) 2002-07-30 2010-11-23 Grunenthal Gmbh Intravenous pharmaceutical form of administration
DE10234784A1 (de) * 2002-07-30 2004-02-19 Günenthal GmbH Intravenös applizierbare, pharmazeutische Darreichungsform
US20040102476A1 (en) * 2002-11-25 2004-05-27 Chan Tai Wah High concentration formulations of opioids and opioid derivatives
JP2006523609A (ja) * 2002-12-31 2006-10-19 アルタス ファーマシューティカルズ インコーポレイテッド タンパク質結晶およびイオン性ポリマーの複合体
RU2357750C2 (ru) * 2002-12-31 2009-06-10 Элтус Фармасьютикалз Инк. Кристаллы человеческого гормона роста и способы их получения
GB0300531D0 (en) 2003-01-10 2003-02-12 West Pharm Serv Drug Res Ltd Pharmaceutical compositions
US20090023629A1 (en) * 2005-12-23 2009-01-22 Altus Pharmaceuticals Inc. Compositions comprising polycation-complexed protein crystals and methods of treatment using them
CA2672284C (en) * 2006-12-18 2014-08-26 Altus Pharmaceuticals Inc. Human growth hormone formulations
FI20075091A0 (fi) * 2007-02-09 2007-02-09 Kim Lemberg Noroksimorfoni käytettäväksi lääkeaineena
WO2008106571A2 (en) * 2007-02-28 2008-09-04 Abbott Laboratories Sustained release parenteral formulations of buprenorphine
US9125867B2 (en) * 2010-02-24 2015-09-08 Invincible Biotechnology Diversion- and/or abuse-resistant compositions and methods for making the same
GB2513060B (en) * 2010-06-08 2015-01-07 Rb Pharmaceuticals Ltd Microparticle buprenorphine suspension
US9272044B2 (en) 2010-06-08 2016-03-01 Indivior Uk Limited Injectable flowable composition buprenorphine
GB201404139D0 (en) 2014-03-10 2014-04-23 Rb Pharmaceuticals Ltd Sustained release buprenorphine solution formulations
CA3015557C (en) 2014-11-07 2019-07-16 Indivior Uk Limited The use of sustained-release buprenorphine formulations for the treatment of pain or opioid use disorders
US10646484B2 (en) 2017-06-16 2020-05-12 Indivior Uk Limited Methods to treat opioid use disorder
WO2021073548A1 (zh) * 2019-10-16 2021-04-22 广东东阳光药业有限公司 一种药物组合物
WO2022175977A1 (en) * 2021-02-18 2022-08-25 Navin Saxena Research And Technology Private Limited A biodegradable implant composition and process for long term delivery of buprenorphine and use thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB784659A (en) * 1954-11-26 1957-10-16 Upjohn Co Therapeutic compositions and aqueous suspensions thereof
US3337406A (en) * 1963-12-12 1967-08-22 Mar Sal Inc Treatment of arteriosclerotic diseases
EP0031603A1 (en) * 1979-12-31 1981-07-08 American Cyanamid Company Pharmaceutical composition of matter
US4963367A (en) * 1984-04-27 1990-10-16 Medaphore, Inc. Drug delivery compositions and methods
US4599354A (en) * 1985-03-11 1986-07-08 Morton Shulman Composition and method for producing prolonged pain relief

Also Published As

Publication number Publication date
ATE121631T1 (de) 1995-05-15
CA2077641A1 (en) 1991-09-21
JPH05507466A (ja) 1993-10-28
NL9000634A (nl) 1991-10-16
WO1991014455A1 (en) 1991-10-03
ES2074269T3 (es) 1995-09-01
CA2077641C (en) 2001-07-03
FI924019L (fi) 1992-09-08
NO923429L (no) 1992-09-17
US5346903A (en) 1994-09-13
EP0521070B1 (en) 1995-04-26
GR3015940T3 (en) 1995-07-31
DE69109279T2 (de) 1995-11-09
FI98890B (fi) 1997-05-30
FI924019A0 (fi) 1992-09-08
AU7558091A (en) 1991-10-21
AU646857B2 (en) 1994-03-10
NO300114B1 (no) 1997-04-14
DE69109279D1 (de) 1995-06-01
FI98890C (fi) 1997-09-10
EP0521070A1 (en) 1993-01-07
DK0521070T3 (da) 1995-05-22
NO923429D0 (no) 1992-09-03

Similar Documents

Publication Publication Date Title
BR1100601A (pt) Preparação de uma suspensão aquosa para injeção para combater dor; processo para produzir a mesma; e uso desta para alìvio da dor
US5945121A (en) Liposome eye drops
ATE149828T1 (de) Arzneistofformulierung zur parenteralen anwendung
US5916583A (en) Precipitation of one or more active compounds in situ
BR0214967A (pt) Composto, sal famaceuticamente aceitável, processo para a preparação de um composto, composição farmacêutica, uso de um composto e método de tratar um distúrbio de um paciente
ES2118630T3 (es) Composicion que contiene un aerogel, procedimiento para su preparacion, asi como su empleo.
KR920702217A (ko) 말라리아 치료 조성물
JPS55147228A (en) Fat emulsion for intravenous injection
UA72882C2 (uk) Спосіб лікування нестабільності чи надактивності сечового міхура, фармацевтична композиція з регульованим вивільненням та використання толтеродину
GB9400981D0 (en) Preparation of microparticles
BR9508295A (pt) Utilização de compostos de tiazol e tiadiazol composto composição farmacêutica e processos para preparar um composto e tratar distúrbios que respondem a ligantes de receptor d3 de dopamina
FI963978A0 (fi) Solususpensioiden preparointi ja stabilointi
ID29206A (id) Komposisi yang mengandung partikel-partikel padat halus
US4599354A (en) Composition and method for producing prolonged pain relief
CH676549A5 (pt)
Mautner et al. Antagonistic effect of asphyxia to curare paralysis of the vagus nerve
ES2088870T3 (es) Un derivado de benzoxazinorrifamicina sustituida, un procedimiento para preparar el mismo y un agente antibacteriano que contiene el mismo.
JPH04503805A (ja) コカイン常用癖の治療薬
Rose The effect of cortin and desoxycorticosterone acetate on the ability of the adrenalectomized rat to inactivate histamine
Adriani et al. Some recent studies on the clinical pharmacology of local anesthetics of practical significance
EP0135189A3 (en) Pharmaceutically useful malonamides
KR950010896A (ko) 근시의 예방 및 치료용 조성물
Burn et al. The effect of phenoxybenzamine and of tolazoline on the response to sympathetic stimulation
US4213981A (en) Injectable anesthetic
DE69524462T2 (de) Verwendung der Seminalribonuklease als antimetastatische Verbindung

Legal Events

Date Code Title Description
AN Processing applications according to articles 230 and 231 of law 9279/96: notification of filing an application
HHFK Processing applications according to articles 230 and 231 of law 9.279/96: republication
MT Patent procedure suspended until requirement met - articles 230 and 231 of law 9279/96
CAF Processing applications according to articles 230 and 231 of law 9.279/96: notification for applicant submission of comments
TKX1 Grant procedure suspended (cancelled) - according to articles 230 and 231 of law 9279/96
FGAN Processing applications according to articles 230 and 231 of law 9.279/96: granting
NB Patent issued - articles 230 and 231 of law 9279/96